We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Acceptys and OncoMab Announce Integration of Human Antibody Drug Development Pipeline and Operations

News   Dec 26, 2005

 
Acceptys and OncoMab Announce Integration of Human Antibody Drug Development Pipeline and Operations
 
 
 

RELATED ARTICLES

Obesity and Cancer: ‘Fat-clogged’ Immune Cells Fail to Fight Tumors

News

Researchers have gained a new understanding of the link between obesity and cancer. In the presence of excess fat, the immune surveillance system fails due to an obesity-fueled lipid accumulation in natural killer (NK) cells, preventing their cellular metabolism and trafficking.

READ MORE

Paving the Way to Regulate Out of Control Immune Responses

News

A potential new pathway has been found to regulate immune response and control inflammatory diseases of the central nervous system such as meningitis and sepsis.

READ MORE

Promising Marker for Immune Invasion and Immunotherapy Failure

News

An extracellular matrix gene signature has been identified which is associated with response to immunotherapy, and provides a hypothesis about why some people don't respond.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE